These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 26223844

  • 1. Renal Involvement in Inflammatory Bowel Diseases.
    Corica D, Romano C.
    J Crohns Colitis; 2016 Feb; 10(2):226-35. PubMed ID: 26223844
    [Abstract] [Full Text] [Related]

  • 2. [Tubulointerstitiel nephritis and Crohn's disease, nephrotoxicity or extraintestinal manifestation of Crohn's disease? About a case].
    Treffel M, Champigneulle J, Meibody F, Laurain E, Frimat L, Busby-Venner H.
    Nephrol Ther; 2019 Mar; 15(1):59-62. PubMed ID: 30503098
    [Abstract] [Full Text] [Related]

  • 3. Extraintestinal manifestations and complications in inflammatory bowel diseases.
    Rothfuss KS, Stange EF, Herrlinger KR.
    World J Gastroenterol; 2006 Aug 14; 12(30):4819-31. PubMed ID: 16937463
    [Abstract] [Full Text] [Related]

  • 4. Insights into renal and urological complications of inflammatory bowel disease.
    Singh A, Khanna T, Mahendru D, Kahlon J, Kumar V, Sohal A, Yang J.
    World J Nephrol; 2024 Sep 25; 13(3):96574. PubMed ID: 39351187
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature.
    Angeletti A, Arrigo S, Madeo A, Molteni M, Vietti E, Arcuri L, Coccia MC, Gandullia P, Ghiggeri GM.
    BMC Nephrol; 2021 Apr 22; 22(1):146. PubMed ID: 33888087
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease.
    Andrisani G, Guidi L, Papa A, Armuzzi A.
    Eur Rev Med Pharmacol Sci; 2012 Jul 22; 16(7):890-901. PubMed ID: 22953637
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Renal and Urinary Manifestations of Inflammatory Bowel Disease].
    Kim YN, Jung Y.
    Korean J Gastroenterol; 2019 May 25; 73(5):260-268. PubMed ID: 31132832
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extraintestinal manifestations of inflammatory bowel disease.
    Urlep D, Mamula P, Baldassano R.
    Minerva Gastroenterol Dietol; 2005 Jun 25; 51(2):147-63. PubMed ID: 15990704
    [Abstract] [Full Text] [Related]

  • 19. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M.
    Acta Med Croatica; 2013 Apr 25; 67(2):195-201. PubMed ID: 24471303
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.